Nidan Laboratories and Healthcare (NSE:NIDAN) Research & Development: ₹0.0 Mil (TTM As of Mar. 2025)


NSE:NIDAN Nidan Laboratories and Healthcare Ltd NSE:NIDAN
67 GF Score
Price ₹13.60
View Full Analysis

What is Nidan Laboratories and Healthcare Research & Development?

Nidan Laboratories and Healthcare NSE:NIDAN -3.89% 67 Research & Development is ₹0.0 Mil as of Mar. 2025. GuruFocus rates NSE:NIDAN with a GF Score™ of 67/100.

Research & Development is the aggregate amount of research and development expenses during the year. Nidan Laboratories and Healthcare's Research & Development for the six months ended in Mar. 2025 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.0 Mil.

Nidan Laboratories and Healthcare  (NSE:NIDAN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nidan Laboratories and Healthcare Research & Development Related Terms

Nidan Laboratories and Healthcare Research & Development Historical Data

* Premium members only.

The historical data trend for Nidan Laboratories and Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nidan Laboratories and Healthcare Research & Development Chart

Nidan Laboratories and Healthcare Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Nidan Laboratories and Healthcare Semi-Annual Data
Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NSE:NIDAN
67GF Score
Nidan Laboratories and Healthcare Ltd NSE:NIDAN
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nidan Laboratories and Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a Research & Development of ₹0.0 Mil as of Mar. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nidan Laboratories and Healthcare and its competitors.
Is Nidan Laboratories and Healthcare's Research & Development too high?
Nidan Laboratories and Healthcare's current Research & Development is ₹0.0 Mil. Overall, Nidan Laboratories and Healthcare has a GF Score™ of 67/100, reflecting its overall financial health beyond just this single metric.
How does Nidan Laboratories and Healthcare's Research & Development compare to TMO and DHR?
Nidan Laboratories and Healthcare's Research & Development of ₹0.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Diagnostics & Research company?
A good Research & Development depends on the Medical Diagnostics & Research industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nidan Laboratories and Healthcare and its competitors. Nidan Laboratories and Healthcare's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nidan Laboratories and Healthcare stock overvalued right now?
Nidan Laboratories and Healthcare (NSE:NIDAN) has a current Research & Development of ₹0.0 Mil. The current Research & Development is ₹0.0 Mil. Nidan Laboratories and Healthcare's overall GF Score™ is 67/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nidan Laboratories and Healthcare (NSE:NIDAN), the current Research & Development is ₹0.0 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Nidan Laboratories and Healthcare Business Description

Address Vartak Road, SY No. 294/A H. No. 18, Swapnshilpa Bunglow, Behind Aarti Apartment, Virar West, Palghar, Virar, MH, IND, 401303
Nidan Laboratories and Healthcare Ltd offer diagnostic services including radiology, neurology, cardiology, dental as well as pathology services. The company provides pathology tests ranging from basic biochemistry and clinical pathology to cytogenetic and high-end molecular diagnostic tests, and radiology tests ranging from basic echocardiograms, X-Rays, and ultrasounds to radiology tests including computerized tomography scans, magnetic resonance imaging scans.
67GF Score

Get the complete analysis for NSE:NIDAN

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹13.60
Price